Cargando…

Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II

BACKGROUND: Topoisomerase II is critical for DNA replication, transcription and chromosome segregation and is a well validated target of anti-neoplastic drugs including the anthracyclines and epipodophyllotoxins. However, these drugs are limited by common tumor resistance mechanisms and side-effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hawtin, Rachael E., Stockett, David E., Byl, Jo Ann W., McDowell, Robert S., Tan, Nguyen, Arkin, Michelle R., Conroy, Andrew, Yang, Wenjin, Osheroff, Neil, Fox, Judith A.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855444/ https://www.ncbi.nlm.nih.gov/pubmed/20419121 http://dx.doi.org/10.1371/journal.pone.0010186

Ejemplares similares

Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo
por: Scatena, Caroline D., et al.
Publicado: (2010)

Etoposide Quinone Is a Covalent Poison of Human Topoisomerase IIβ
por: Smith, Nicholas A., et al.
Publicado: (2014)

Natural Products as Topoisomerase II Poisons: Effects of Thymoquinone on DNA Cleavage Mediated by Human Topoisomerase IIα
por: Ashley, Rachel E., et al.
Publicado: (2014)

Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance
por: Aldred, Katie J., et al.
Publicado: (2013)

Role of the Water–Metal Ion Bridge in Mediating Interactions between Quinolones and Escherichia coli Topoisomerase IV
por: Aldred, Katie J., et al.
Publicado: (2014)

Topoisomerase II Is Crucial for Fork Convergence during Vertebrate Replication Termination
por: Heintzman, Darren R., et al.
Publicado: (2019)

Actions of a Novel Bacterial Topoisomerase Inhibitor against Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks
por: Dauda, Soziema E., et al.
Publicado: (2023)

Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks
por: Hawtin, Rachael Elizabeth, et al.
Publicado: (2010)

Mechanism of Quinolone Action and Resistance
por: Aldred, Katie J., et al.
Publicado: (2014)

The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing
por: Deweese, Joseph E., et al.
Publicado: (2009)

Direct Monitoring of the Strand Passage Reaction of DNA Topoisomerase II Triggers Checkpoint Activation
por: Furniss, Katherine L., et al.
Publicado: (2013)

No Time to Relax and Unwind: Exploration of Topoisomerases and a Growing Field of Study
por: Deweese, Joseph E., et al.
Publicado: (2023)

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
por: Grossman, Scott, et al.
Publicado: (2023)

Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences
por: Infante Lara, Lorena, et al.
Publicado: (2018)

Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models
por: Gravina, Giovanni Luca, et al.
Publicado: (2017)

A T5 Exonuclease-Based Assay for DNA Topoisomerases and DNA Intercalators
por: Deng, Zifang, et al.
Publicado: (2021)

Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
por: Farouk, Faten, et al.
Publicado: (2023)

Interlinked DNA nano-circles for measuring topoisomerase II activity at the level of single decatenation events
por: Kristoffersen, Emil L., et al.
Publicado: (2017)

Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells
por: Jasek-Gajda, Ewa, et al.
Publicado: (2019)

Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia
por: Jamieson, Gene C., et al.
Publicado: (2016)

Mutational Diversity in the Quinolone Resistance-Determining Regions of Type-II Topoisomerases of Salmonella Serovars
por: Shaheen, Aqsa, et al.
Publicado: (2021)

Interactions between Quinolones and Bacillus anthracis Gyrase and the Basis of Drug Resistance
por: Ashley, Rachel E., et al.
Publicado: (2017)

Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in human colon cancer HCT116 cells
por: Juchem, André Luiz Mendes, et al.
Publicado: (2023)

Human topoisomerase IIα uses a two-metal-ion mechanism for DNA cleavage
por: Deweese, Joseph E., et al.
Publicado: (2008)

Activities of gyrase and topoisomerase IV on positively supercoiled DNA
por: Ashley, Rachel E., et al.
Publicado: (2017)

Plasmid-mediated quinolone resistance (PMQR) and mutations in the topoisomerase genes of Salmonella enterica strains from Brazil
por: Ferrari, Rafaela, et al.
Publicado: (2013)

DNA Gyrase and Topoisomerase IV Mutations and their effect on Quinolones Resistant Proteus mirabilis among UTIs Patients
por: Abdelkreem, Randa H, et al.
Publicado: (2020)

Transition Metal Intercalators as Anticancer Agents—Recent Advances
por: Deo, Krishant M., et al.
Publicado: (2016)

Mms22p protects Saccharomyces cerevisiae from DNA damage induced by topoisomerase II
por: Baldwin, E. L., et al.
Publicado: (2005)

Molecular mechanism of topoisomerase poisoning by the peptide antibiotic albicidin
por: Michalczyk, Elizabeth, et al.
Publicado: (2023)

Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β
por: Ortega, Jose Antonio, et al.
Publicado: (2020)

DNA topoisomerases as molecular targets for anticancer drugs
por: Buzun, Kamila, et al.
Publicado: (2020)

Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase
por: Znojek, P, et al.
Publicado: (2014)

Telling Your Right Hand from Your Left: The Effects of DNA Supercoil Handedness on the Actions of Type II Topoisomerases
por: Jian, Jeffrey Y., et al.
Publicado: (2023)

Breakage-Reunion Domain of Streptococcus pneumoniae Topoisomerase IV: Crystal Structure of a Gram-Positive Quinolone Target
por: Laponogov, Ivan, et al.
Publicado: (2007)

The geometry of DNA supercoils modulates the DNA cleavage activity of human topoisomerase I
por: Gentry, Amanda C., et al.
Publicado: (2011)

A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases
por: Schmidt, Bryan H., et al.
Publicado: (2010)

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
por: Matias-Barrios, Victor M., et al.
Publicado: (2021)

Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
por: Jain, Chetan Kumar, et al.
Publicado: (2017)

Effects of Olive Metabolites on DNA Cleavage Mediated by Human Type II Topoisomerases
por: Vann, Kendra R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n97pro23qm30hd87i6fav0q3l2